ACB
Price
$5.42
Change
-$0.20 (-3.56%)
Updated
Aug 29 closing price
Capitalization
302.02M
65 days until earnings call
ALVO
Price
$8.07
Change
+$0.02 (+0.25%)
Updated
Aug 29 closing price
Capitalization
2.51B
71 days until earnings call
Interact to see
Advertisement

ACB vs ALVO

Header iconACB vs ALVO Comparison
Open Charts ACB vs ALVOBanner chart's image
Aurora Cannabis
Price$5.42
Change-$0.20 (-3.56%)
Volume$1.45M
Capitalization302.02M
Alvotech
Price$8.07
Change+$0.02 (+0.25%)
Volume$229.92K
Capitalization2.51B
ACB vs ALVO Comparison Chart in %
Loading...
ACB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ALVO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ACB vs. ALVO commentary
Sep 02, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACB is a StrongBuy and ALVO is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 02, 2025
Stock price -- (ACB: $5.42 vs. ALVO: $8.07)
Brand notoriety: ACB: Notable vs. ALVO: Not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: ACB: 98% vs. ALVO: 60%
Market capitalization -- ACB: $302.02M vs. ALVO: $2.51B
ACB [@Pharmaceuticals: Generic] is valued at $302.02M. ALVO’s [@Pharmaceuticals: Generic] market capitalization is $2.51B. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $69.31B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.86B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ACB’s FA Score shows that 0 FA rating(s) are green whileALVO’s FA Score has 1 green FA rating(s).

  • ACB’s FA Score: 0 green, 5 red.
  • ALVO’s FA Score: 1 green, 4 red.
According to our system of comparison, both ACB and ALVO are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ACB’s TA Score shows that 6 TA indicator(s) are bullish while ALVO’s TA Score has 3 bullish TA indicator(s).

  • ACB’s TA Score: 6 bullish, 5 bearish.
  • ALVO’s TA Score: 3 bullish, 3 bearish.
According to our system of comparison, ACB is a better buy in the short-term than ALVO.

Price Growth

ACB (@Pharmaceuticals: Generic) experienced а +8.62% price change this week, while ALVO (@Pharmaceuticals: Generic) price change was -4.50% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +1.55%. For the same industry, the average monthly price growth was +67.47%, and the average quarterly price growth was +80.21%.

Reported Earning Dates

ACB is expected to report earnings on Nov 06, 2025.

ALVO is expected to report earnings on Nov 12, 2025.

Industries' Descriptions

@Pharmaceuticals: Generic (+1.55% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ALVO($2.52B) has a higher market cap than ACB($302M). ALVO has higher P/E ratio than ACB: ALVO (35.09) vs ACB (19.44). ACB YTD gains are higher at: 27.529 vs. ALVO (-39.002). ALVO has higher annual earnings (EBITDA): 207M vs. ACB (26.6M). ALVO has more cash in the bank: 151M vs. ACB (140M). ACB has less debt than ALVO: ACB (102M) vs ALVO (1.27B). ALVO has higher revenues than ACB: ALVO (560M) vs ACB (358M).
ACBALVOACB / ALVO
Capitalization302M2.52B12%
EBITDA26.6M207M13%
Gain YTD27.529-39.002-71%
P/E Ratio19.4435.0955%
Revenue358M560M64%
Total Cash140M151M93%
Total Debt102M1.27B8%
FUNDAMENTALS RATINGS
ACB: Fundamental Ratings
ACB
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
59
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
92
PRICE GROWTH RATING
1..100
49
P/E GROWTH RATING
1..100
92
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ACBALVO
RSI
ODDS (%)
Bearish Trend 4 days ago
90%
N/A
Stochastic
ODDS (%)
Bearish Trend 4 days ago
89%
Bullish Trend 4 days ago
49%
Momentum
ODDS (%)
Bullish Trend 4 days ago
80%
Bullish Trend 4 days ago
47%
MACD
ODDS (%)
Bullish Trend 4 days ago
89%
Bearish Trend 4 days ago
51%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
81%
Bearish Trend 4 days ago
63%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
78%
Bearish Trend 4 days ago
66%
Advances
ODDS (%)
Bullish Trend 5 days ago
78%
Bullish Trend 4 days ago
64%
Declines
ODDS (%)
Bearish Trend 13 days ago
88%
Bearish Trend 6 days ago
68%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 7 days ago
52%
Aroon
ODDS (%)
Bullish Trend 4 days ago
57%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
ACB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ALVO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ONXGF1.460.15
+11.06%
Onyx Gold Corp
CSLLY69.330.37
+0.54%
CSL Ltd.
CHFHY5.85N/A
N/A
China Foods Ltd.
TELDF2.67N/A
N/A
Telefonica Deutschland Holding AG
KPIFF0.04N/A
-10.40%
Edgewater Wireless Systems, Inc.

ACB and

Correlation & Price change

A.I.dvisor indicates that over the last year, ACB has been loosely correlated with SNDL. These tickers have moved in lockstep 65% of the time. This A.I.-generated data suggests there is some statistical probability that if ACB jumps, then SNDL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACB
1D Price
Change %
ACB100%
-3.56%
SNDL - ACB
65%
Loosely correlated
-0.37%
CGC - ACB
64%
Loosely correlated
-4.26%
OGI - ACB
62%
Loosely correlated
N/A
CRON - ACB
55%
Loosely correlated
N/A
TLRY - ACB
54%
Loosely correlated
-6.12%
More

ALVO and

Correlation & Price change

A.I.dvisor tells us that ALVO and EBS have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ALVO and EBS's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALVO
1D Price
Change %
ALVO100%
+0.25%
EBS - ALVO
27%
Poorly correlated
-1.07%
CRON - ALVO
23%
Poorly correlated
N/A
ACB - ALVO
22%
Poorly correlated
-3.56%
PAHC - ALVO
21%
Poorly correlated
-3.61%
PBH - ALVO
21%
Poorly correlated
+1.16%
More